Refsum's disease;LA MALADIE DE REFSUM

Revue de Medecine Interne

Volumn 17, Issue 5, 1996, Pages 391-398

  Hochner, I ^a   Blickle, J F ^a   Brogard, J M ^a  

^a HUS   (France)

Author keywords

peripheral neuropathy; phytanic acid; Refsum's disease; retinitis pigmentosa

Indexed keywords

FATTY ACID; PHYTANIC ACID;

ADULT; ATAXIA; AUTOSOMAL RECESSIVE INHERITANCE; DIET; ENZYME DEFICIENCY; HUMAN; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; REFSUM DISEASE; RETINITIS PIGMENTOSA; REVIEW;

EID: 0029897024     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)83739-8     Document Type: Article

References (37)

1. Refsum S. Heredopathia atacticapolyneuritiformis, Acta Physiol Scand 1946;38(Suppl):9-303
2. Thiébaut M, Lemoyne J, Guillaumat L. Deux syndromes otoneuro-oculistiques d'origine congénitale, leurs rapports avec les phacomatoses de van der Hoeve et autres dysplasies neuro-ectodermiques. Rev Neurol 1939;72:71-5
3. Klenk E, Kahlke W. Über das Vorkommen der 3,7,11,15-Tetramehyl-hexadecansaure in den Cholesterinestern und anderen Lipoidfraktionen der Organe bei einem Krankheitsfall unbekannter Genese. Hoppe-Seyler's Z Physiol Chem 1963;333:133-9
4. Steinberg D. Refsum disease. In: PG Dyck, PK Thomas, EH Lambert, R Bunge, eds. Peripheral Neuropathy, vol II. Philadelphia:WB Saunders, 1989;1533-50
5. Steinberg D. Refsum disease. In : CR Scriver, AL Beaudet, WS Sly, D Valle, eds. The metabolic basis of inherited diseases. 6th ed. New York:McGraw-Hill, 1993;389-98
6. Claridge KG, Gibberd FB, Sidey MC. Refsum disease: the presentation and ophtalmie aspects of Refsum disease in a serie of 23 patients. Eye 1992;6:371-5
7. Gibberd FB, Billimoria JD, Goldman JM et al. HAP: Refsum's disease. Acta Neurol Scand 1985;72:1-17
8. Leys D, Petit H, Bonte-Adnet C et al. Refsum's disease revealed by cardiac disorders Lancet 1989;i:621
9. Milliaire A, Warembourg A, Leys D et al. La maladie de Refsum : À propos de deux cas révélés par une myocardiopathie. Ann Cardial Angéiol 1990;39:173-8
10. Graham R, Hansell MB, Gibberd FB et al. Skeletal abnormalities in Refsum's disease. Br J Radiol 1990;63:537-41
11. Pabicco RC, Gruebel BJ, McKenna BA et al. Renal involvement in Refsum's disease. Am J Med 1981;70:1136-43
12. Allen IV, Smallow M, Nevin NC, McCormick D. Clinicopathological study of Refsum's disease with particular reference to fatal complications. J Neurol Neurosurg Psychiatry 1978;41:323-32
13. Petit H, Leys D, Skjedlal OH et al. La maladie de Refsum. Corrélations épidémiologiques cliniques et biologiques : six cas. Rev Neurol 1986;142:500-8
14. Ashenhurst EM, Millar JH, Milliken TG. Refsum's disease affecting two brothers and a sister. Br Med J 1958;2:415-7
15. Avigan J, Steinberg D, Gutman A, Mize CE, Milne GWA. Alpha decarboxylation, an important pathway for degradation of phytanic acid. Biochem Biophys Res Commun. 1966;24:838-44
16. Billimoria JD, Gibberd FB, Clemens ME, Whitelaw MN. Metabolism of phytanic acid in Refsum's disease. Lancet 1982;i:194
17. Patton S, Benson AA. Phytol metabolism in the bovine. Biochem Biophys Acta 1966;125:22-32
18. Stokke O, Refsum S. Refsum's disease and metabolism of phytanic acid. Lancet 1982;i:906-7
19. Brenton DP, Krywawych S. 3-Methyladipate excretion in Refsum disease. Lancet 1982;i:624
20. Skjedlal OH, Nyberg-Hansen R, Stokke O. Neurological disorders and phytanic acid metabolism. Acta Neurol Scand 1988;78:324-8
21. Wanders RJ, Heymans HS, Schutgens RB et al. Peroxisomal disorders in classical Refsum disease:comparison with the infantile form of Refsum's disease. J Neurol Sci 1988;84:147-55
22. Glomset JA, Gelb MH, Farnworth CC. Prenylproteins in eukaryotic cells: a new type of membrane anchor. TIBS 1990;15:139-42
23. Bar Sag I D. Ras proteins:Biological effects and biochemical targets. Anticancer Res 1989;9:1427-38
24. Herndon JH, Steinberg D, Uhldendorf BW, Fales HM. Refsum's disease: Characterization of the enzyme defect in cell culture. J Clin Invest 1969;48:1017-32
25. Herndon JH, Steinberg D, Uhldendorf BW. Refsum's disease: Defective oxydation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes. N Engl J Med 1969;281:1034-38
26. Skjedlal OH, Stokke O, Refsum S. Clinical and biochemical heterogenicity in conditions with phytanic acid accumulation. J Neurol Sci 1987;77:87-96
27. Staunton H, Murphy S, Dervan P. The effect of Prednisolone in Refsum's disease, Ir J Med Sci 1989;158:50-1
28. Steinberg D, Mize CE, Herndon JH, et al. Phytanic acid in patients with Refsum's syndrome and response to dietary treatement. Arch Int Med 1970;125:75-87
29. Sahgal V, Olsen WO. Heredopathia Atactica polyneuritiformis: A new case with special reference to dietary treatment. Arch Int Med 1975;135:585-7
30. Eldjarn L, Try K, Stokke O, et al. Dietary effects on serum phytanic acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis. Lancet 1966;i:691-3
31. Djupesland G, Flottorp G, Refsum S. Phytanic acid storage disease: Hearing maintained after 15 years of treatement. Neurology 1983;33:237-40
32. Coppack SW, Evans R, Gibberd FB, Clemens ME, Billimoria JD. Can patients with Refsum's disease safely eat green vegetables? Br Med J 1988;290:828
33. Gibberd FB, Billimoria J, Page NGR, Restas S. Heredopathia Atactica polyneuritiformis (Refsum's disease) treated by diet and plasma exchange. Lancet 1979;i:575-8
34. Harari D, Gibberd D, Dick FB et al. Plasma exchange in the treatment of Refsum's disease. J Neurol Neurosurg Psychiatry 1991;54:614-7
35. Leppert D, Schanz U, Burger J, Blau N, Waespe W. Long-term plasma exchange in a case of Refsum's disease. Eur Arch Clin Neurosci 1991;241:82-4
36. Tauveron I, Thomsen M, Giauque JP, Laudat MH, Luton JP. Maladie de Refsum avec 25 ans de recul : Un pronostic à long terme transformé par la thérapeutique diététique. Presse Méd 1991;20:1232
37. Colart F, Tielemans C, Dratwa M et al. Mobilisation of tissue stores of phytanic acid by plamsa exchange in HAP. Plasma Ther Trans Technol 1985;6:457-60